Sumitomo Pharma Co., Ltd. (FRA:DPM)

Sumitomo Pharma Revenue

Sumitomo Pharma had revenue of 119.12B JPY in the quarter ending September 30, 2025, with 32.25% growth. This brings the company's revenue in the last twelve months to 445.21B, up 29.92% year-over-year. In the fiscal year ending March 31, 2025, Sumitomo Pharma had annual revenue of 398.83B with 26.79% growth.

• Revenue (ttm): 445.21B JPY
• Revenue Growth: +29.92%
• P/S Ratio: 2.21
• Revenue / Employee: 116.18M JPY
• Employees: 3,832
• Market Cap: 5.66B EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	398.83B	84.27B	26.79%
Mar 31, 2024	314.56B	-240.99B	-43.38%
Mar 31, 2023	555.54B	-4.49B	-0.80%
Mar 31, 2022	560.04B	44.08B	8.54%
Mar 31, 2021	515.95B	33.22B	6.88%